TLDRs; Visa shares dip 1.5% as China deal fuels cautious investor sentiment. Integration with UnionPay expands cross-border payouts into mainland China. AnalystsTLDRs; Visa shares dip 1.5% as China deal fuels cautious investor sentiment. Integration with UnionPay expands cross-border payouts into mainland China. Analysts

Visa (V) Stock; Retreats After Announcing Visa Direct Integration with UnionPay

2026/03/05 17:11
3분 읽기
이 콘텐츠에 대한 의견이나 우려 사항이 있으시면 [email protected]으로 연락주시기 바랍니다

TLDRs;

  • Visa shares dip 1.5% as China deal fuels cautious investor sentiment.
  • Integration with UnionPay expands cross-border payouts into mainland China.
  • Analysts maintain bullish outlook despite market volatility and regulatory concerns.
  • Fiscal Q1 growth strong, but short-term stock reaction remains muted.

Visa (NYSE: V) shares fell 1.47% to close at $328.93 on Tuesday, reacting to the company’s announcement that its Visa Direct platform will integrate with UnionPay International. Despite the dip during regular trading, shares remained largely unchanged in after-hours sessions.

Investors appeared to weigh the potential long-term benefits of Visa’s expansion into mainland China against near-term market uncertainties.

The retreat highlights the sensitivity of payment stocks to broader economic conditions, including consumer spending trends and cross-border transaction volumes. Visa’s real-time payout offerings, which have generated optimism among some analysts, are still facing scrutiny as market participants debate the scope of growth in the company’s core card network.

China Expansion via Visa Direct

The integration with UnionPay International’s MoneyExpress service is set to facilitate cross-border remittances and business-to-consumer payouts into mainland China, a market with significant growth potential for digital payments. The launch is planned for the first half of 2026, marking a major milestone for Visa’s international expansion strategy.


V Stock Card
Visa Inc., V

Larry Wang, also commenting on the deal, emphasized that remittances serve as a “key livelihood link” for many families, underscoring the social as well as economic impact of the integration.

Analyst Optimism Persists Amid Short-Term Volatility

While Visa’s stock slipped in Tuesday’s session, analysts remain positive on the company’s medium-term prospects. Daiwa Securities maintained an “Outperform” rating on Visa, with a $370 price target.

The firm cited the recent pullback as an opportunity for long-term investors, highlighting projected underlying EPS growth of 13% to 14%, supported by Visa Direct and other value-added services.

Comparatively, Mastercard also received an Outperform rating, reinforcing a favorable view of the payments sector despite market jitters. Trading volume in Visa shares exceeded recent averages, suggesting that investors are still adjusting positions following the company’s strong earnings report last week.

Strong Fiscal Q1 Results and Market Context

Visa reported fiscal first-quarter net revenue of $10.9 billion, a 15% increase year-over-year. Adjusted earnings per share came in at $3.17. CEO Ryan McInerney described the quarter as “very strong,” noting the company’s ability to return $5.1 billion to shareholders through buybacks and dividends. A $0.670 quarterly dividend is scheduled for March 2 to shareholders of record on Feb. 10.

Despite robust fundamentals, the stock’s muted reaction reflects wider market concerns, including recent tech sector volatility and geopolitical tensions affecting oil prices. The next major macroeconomic checkpoint will be the delayed U.S. labor report, which could influence interest rates and impact high-multiple, defensive stocks like Visa.

Looking Ahead

Investors will be closely monitoring whether Visa can hold near the $330 mark in the coming sessions, and how the Visa Direct rollout in China influences both revenue and investor sentiment. As cross-border payout systems navigate compliance reviews, banking infrastructure challenges, and local regulations, Visa’s ability to execute smoothly will be a key determinant of future stock performance.

The post Visa (V) Stock; Retreats After Announcing Visa Direct Integration with UnionPay appeared first on CoinCentral.

시장 기회
Ucan fix life in1day 로고
Ucan fix life in1day 가격(1)
$0.0004472
$0.0004472$0.0004472
+3.80%
USD
Ucan fix life in1day (1) 실시간 가격 차트
면책 조항: 본 사이트에 재게시된 글들은 공개 플랫폼에서 가져온 것으로 정보 제공 목적으로만 제공됩니다. 이는 반드시 MEXC의 견해를 반영하는 것은 아닙니다. 모든 권리는 원저자에게 있습니다. 제3자의 권리를 침해하는 콘텐츠가 있다고 판단될 경우, [email protected]으로 연락하여 삭제 요청을 해주시기 바랍니다. MEXC는 콘텐츠의 정확성, 완전성 또는 시의적절성에 대해 어떠한 보증도 하지 않으며, 제공된 정보에 기반하여 취해진 어떠한 조치에 대해서도 책임을 지지 않습니다. 본 콘텐츠는 금융, 법률 또는 기타 전문적인 조언을 구성하지 않으며, MEXC의 추천이나 보증으로 간주되어서는 안 됩니다.

추천 콘텐츠

a16z Targets $2 Billion Crypto Fund as Venture Capital Eyes Blockchain Recovery

a16z Targets $2 Billion Crypto Fund as Venture Capital Eyes Blockchain Recovery

Andreessen Horowitz’s crypto division, a16z crypto, is reportedly running $2 billion for its fifth crypto investment fund. This move from a firm is happening when
공유하기
Thenewscrypto2026/03/05 20:29
ArtGis Finance Partners with MetaXR to Expand its DeFi Offerings in the Metaverse

ArtGis Finance Partners with MetaXR to Expand its DeFi Offerings in the Metaverse

By using this collaboration, ArtGis utilizes MetaXR’s infrastructure to widen access to its assets and enable its customers to interact with the metaverse.
공유하기
Blockchainreporter2025/09/18 00:07
Health Insurers To Cover Covid Vaccines Despite RFK, Jr. Moves

Health Insurers To Cover Covid Vaccines Despite RFK, Jr. Moves

The post Health Insurers To Cover Covid Vaccines Despite RFK, Jr. Moves appeared on BitcoinEthereumNews.com. The nation’s biggest health insurance companies will continue to cover vaccinations – including those against Covid-19 and seasonal flu – previously recommended by a federal advisory committee, America’s Health Insurance Plans said Wednesday, Sept. 17, 2025. In this photo is a free flu and Covid-19 vaccine shots available sign, CVS, Queens, New York. (Photo by: Lindsey Nicholson/Universal Images Group via Getty Images) UCG/Universal Images Group via Getty Images The nation’s biggest health insurance companies will continue to cover vaccinations – including those against Covid-19 and seasonal flu – previously recommended by a federal advisory committee. The announcement by America’s Health Insurance Plans (AHIP), which includes CVS Health’s Aetna, Humana, Cigna, Centene and an array of Blue Cross and Blue Shield plans as members, comes ahead of the first meeting of the reconstituted Advisory Committee on Immunization Practices, which now has new members chosen by U.S. Health and Human Services Secretary Robert F. Kennedy Jr., a vaccine critic. “Health plans are committed to maintaining and ensuring affordable access to vaccines,” AHIP said in a statement Wednesday. “Health plan coverage decisions for immunizations are grounded in each plan’s ongoing, rigorous review of scientific and clinical evidence, and continual evaluation of multiple sources of data.” The move by AHIP is good news for millions of Americans at a time of year when they flock to drugstores, pharmacies, physician’s offices and outpatient clinics to get their seasonal flu and Covid shots. Kennedy’s changes to U.S. vaccine policy have created confusion across the country over whether certain vaccines long covered by insurance would continue to be. AHIP has now provided some clarity for millions of Americans. “Health plans will continue to cover all ACIP-recommended immunizations that were recommended as of September 1, 2025, including updated formulations of the COVID-19 and influenza vaccines, with no cost-sharing…
공유하기
BitcoinEthereumNews2025/09/18 03:11